Clinical Trials in New York

Showing 5801-5820 of 22,668 trials

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

NCT05232838

The eShunt® System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure. The eShunt System is intended to shunt cerebrospinal fluid from the intracranial subarachnoid space to the venous system for the treatment of patients with normal pressure hydrocephalus, reducing disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

Hydrocephalus, Normal PressureHydrocephalus

CereVasc Inc50 participantsStarted Apr 2022

New Haven, Connecticut, United States • Jacksonville, Florida, United States • Kansas City, Kansas, United States +8 more locations

Active Not RecruitingPhase 3< 1 mile

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744

A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexamethasone versus pomalidomide in combination with dexamethasone.

Multiple Myeloma

AbbVie265 participantsStarted Oct 2018

Tucson, Arizona, United States • Fresno, California, United States • Los Angeles, California, United States +177 more locations

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Find Trials by Condition in New York

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Open-label Treatment in Cushing's Syndrome

Palliative Care at Home for Dementia

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

REal-World Analyses of Stroke - Thrombus Occlusion REtrieval

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study

Home Reported Outcomes in C3G Study

A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study